Anebulo Pharmaceuticals ANEB Stock
Anebulo Pharmaceuticals Price Chart
Anebulo Pharmaceuticals ANEB Financial and Trading Overview
| Anebulo Pharmaceuticals stock price | 0.4 USD |
| Previous Close | 0.39 USD |
| Open | 0.39 USD |
| Bid | 0.35 USD x 250000 |
| Ask | 0.52 USD x 250000 |
| Day's Range | 0.35 - 0.39 USD |
| 52 Week Range | 0.3 - 3.42 USD |
| Volume | 5.94K USD |
| Avg. Volume | 5.21K USD |
| Market Cap | 14.27M USD |
| Beta (5Y Monthly) | -1.874 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.18 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ANEB Valuation Measures
| Enterprise Value | 5.24M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.53846157 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.8134714 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Anebulo Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | -1.874 |
| 52-Week Change | -76.66% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 3.42 USD |
| 52 Week Low | 0.3 USD |
| 50-Day Moving Average | 0.46 USD |
| 200-Day Moving Average | 1.33 USD |
ANEB Share Statistics
| Avg. Volume (3 month) | 5.21K USD |
| Avg. Daily Volume (10-Days) | 4.92K USD |
| Shares Outstanding | 40.78M |
| Float | 24.13M |
| Short Ratio | 1.5 |
| % Held by Insiders | 40.83% |
| % Held by Institutions | 0% |
| Shares Short | 146.37K |
| Short % of Float | 2.19% |
| Short % of Shares Outstanding | 0.36% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | June 30, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -45.042% |
| Return on Equity (ttm) | -69.68% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -7978748 USD |
| Diluted EPS (ttm) | -0.18 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.04M USD |
| Total Cash Per Share (mrq) | 0.22 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 6.242 |
| Book Value Per Share (mrq) | 0.193 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5840233 USD |
| Levered Free Cash Flow (ttm) | -3774629 USD |
Profile of Anebulo Pharmaceuticals
| Country | United States |
| State | TX |
| City | Lakeway |
| Address | 1017 Ranch Road 620 South |
| ZIP | 78734 |
| Phone | 512 598 0931 |
| Website | https://www.anebulo.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company's lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Lakeway, Texas.
Q&A For Anebulo Pharmaceuticals Stock
What is a current ANEB stock price?
Anebulo Pharmaceuticals ANEB stock price today per share is 0.4 USD.
How to purchase Anebulo Pharmaceuticals stock?
You can buy ANEB shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Anebulo Pharmaceuticals?
The stock symbol or ticker of Anebulo Pharmaceuticals is ANEB.
Which industry does the Anebulo Pharmaceuticals company belong to?
The Anebulo Pharmaceuticals industry is Biotechnology.
How many shares does Anebulo Pharmaceuticals have in circulation?
The max supply of Anebulo Pharmaceuticals shares is 40.78M.
What is Anebulo Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Anebulo Pharmaceuticals PE Ratio is now.
What was Anebulo Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Anebulo Pharmaceuticals EPS is -0.18 USD over the trailing 12 months.
Which sector does the Anebulo Pharmaceuticals company belong to?
The Anebulo Pharmaceuticals sector is Healthcare.
Anebulo Pharmaceuticals ANEB included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
- {{ link.label }} {{link}}